Skip to main content
. 2023 Mar 8;28(8):699–705. doi: 10.1093/oncolo/oyad036

Table 2.

Concomitant therapy.

Therapy n (%)
Combination therapy
 Monotherapy 47 (66)
 Combination 24 (34)
Therapeutic agent
 Bicalutamide 4 (17)
 Abiraterone 8 (35)
 Enzalutamide 10 (43)
 Apalutamide 3 (13)
 Docetaxel 1 (4)
 Cabazitaxel 2 (9)
 Radium 223 1 (4)